iNOVA4Health Seminar “Engineering the tumor cell niche to study dormancy and drug resistance in metastatic breast cancer” by Shreyas Rao

Engineering the Tumor Cell Niche to Study Dormancy and Drug Resistance in Metastatic Breast Cancer

On June 6th, iBET had the pleasure of welcoming Shreyas Rao for the iNOVA4Health Seminar “Engineering the tumor cell niche to study dormancy and drug resistance in metastatic breast cancer”.

Prof. Shreyas Rao is an Associate Professor of Chemical and Biological Engineering at the University of Alabama (Tuscaloosa, USA). His research focuses on developing engineering tools to explore the role of tumor microenvironment in cancer progression, therapeutic response and resistance.

During his seminar, Prof. Rao presented his team’s latest work on biomimetic in vitro models, developed using biomaterial scaffolds, to investigate cancer dormancy and drug resistance, particularly in brain metastatic breast cancer.

These engineered systems aim to uncover strategies to re-educate the tumor microenvironment, potentially offering new strategies to halt disease progression and improve patient outcomes.

iBET was also delighted to welcome a group of undergraduate students from the University of Alabama, currently completing a short-term research placement at iBET as part of a Summer Exchange Program organized by Prof. John Kim.

We extend our sincere appreciation to Prof. Rao for his inspiring talk and sharing his valuable expertise with our community.

Related news

iBET Hosts Dr. Ryan Summers (University of Alabama) for Seminar on Paraxanthine Production
June 12, 2026

iBET Hosts Dr. Eduard Ayuso, CTO and Co-founder of DINAMIQS, for Seminar on AAV Manufacturing
May 27, 2026

Advancing Biomaterials Engineering: iBET Welcomes Seminar by Dr. Miguel Castilho
May 22, 2026

iBET Welcomes Dr. Mark Duerkop, CEO and Co-founder of Novasign
March 30, 2026

Building synergies in Cell Therapy: iBET Hosts Dr. Lindsay Davies, NextCell Pharma CSO and QVance CEO
March 18, 2026